Investigating the pathology, molecular pathogenesis and vaccine efficacy of respiratory mycoplasmosis in poultry
Year: 2016
Type: dissertation
Abstract: Mycoplasma gallisepticum is an important respiratory pathogen of chickens with a worldwide distribution and causes massive economic losses in the poultry industry. Over the last 10 years there have been a number of attempts to better understand the molecular basis of the pathogenesis of M. gallisepticum but these studies are hampered by a lack of genetic tools to manipulate the organism and the difficulty experienced in transforming mycoplasmas. There have only been a few studies describing methods for experimental infection of turkeys to compare the pathogenicity, transmissibility and immunogenicity of different strains of M. gallisepticum in turkeys. However, none of these studies used the same criteria to assess infection. The three available M. gallisepticum vaccines have very limited capacity to provide protection against disease. The studies described in this thesis focused on three main aims. The first was to create a M. gallisepticum mutant library using a transposon carrying a promoter-less reporter gene, such as the E. coli alkaline phosphatase gene. This would facilitate the selection of mutants when the transposon inserts in frame within a gene containing an export signal sequence, resulting in the cells expressing detectable alkaline phosphatase. To demonstrate the safety and efficacy of any vaccine candidate, a reproducible infection model, such as the aerosol exposure method developed previously to test vaccine safety and efficacy in chickens using the M. gallisepticum Ap3AS wild type strain, is needed. Therefore the second aim of these studies was to develop a method for reproduction of disease caused by M. gallisepticum in 5-6 week old turkeys using aerosol exposure to cultured organisms, a method that mimics the natural route of infection, and to establish an objective approach to quantifying the lesions induced. The third aim of this study was to evaluate the efficacy of a new generation vaccine (Gap A+ ts-11) in turkeys. The promoter-less transposon was successfully introduced into the M. gallisepticum genome, however further investigation of transport to the mycoplasma cytoplasmic membrane and protein processing using the promoter-less phoA gene was unsuccessful. The development of an aerosol model for infection of turkeys with M. gallisepticum allowed the strain comparison study and the dose response study to be conducted and facilitated understanding of the differences in pathogenicity of two strains of M. gallisepticum and the pathology induced by different doses of M. gallisepticum Ap3AS. Aerosol exposure to cultures containing similar concentrations of strain Ap3AS/ml induced disease of similar severity in both trials based on a number of criteria, with the rates of re-isolation from the choanal cleft, air sacs or trachea, the median gross air sac lesion scores, the mean number of lymphoid nodules in the air sacs, the mean upper tracheal mucosal thickness and the median tracheal mucosal lesion score in the mid trachea not differing significantly between the birds infected by the two different strains (P > 0.05). The mean tracheal mucosal thickness appeared to be reproducible and provided an objective measure of the severity of the respiratory disease caused by MG in turkeys. Collective results of the strain comparison and the dose response studies showed that exposure to an aerosol of a culture containing approximately 107 CCU of M. gallisepticum strain Ap3AS/ml for 15 minutes can induce measurable disease and lesions 14 days after infection in turkeys and that this model should be suitable for future vaccine studies. Macroscopic and microscopic examination of birds vaccinated with a 108 CCU dose of the M. gallisepticum GapA+ ts-11 vaccine by either eye drop or coarse spray was shown to protect against gross air sac lesions and increases in tracheal mucosal thickness, and to result in lower tracheal mucosal lesion scores, suggesting that the strain appears to elicit a substantial level of protection against experimental challenge in turkeys at a dose of 108 CCU.
Author: Dinidu S. Wijesurendra
Institution: The University of Melbourne
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2752196142
